Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
17 20 Search
2024
Development of T follicular helper cell-independent nanoparticle vaccines for SARS-CoV-2 or HIV-1 by targeting ICOSL
npj Vaccines
2024
Synthesizing Efficiency Tools in Radiotherapy to Increase Patient Flow: A Comprehensive Literature Review
Clinical Medicine Insights: Oncology
2024
Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model
European Journal of Pharmaceutics and Biopharmaceutics
2024
Small molecule agents for triple negative breast cancer: Current status and future prospects
Translational Oncology
2023
Molecular and clinical characterization of ICOS expression in breast cancer through large-scale transcriptome data
PLOS ONE
2023
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model
Frontiers in Oncology
2023
Expression and prognosis of inducible T‐cell co‐stimulator and its ligand in Chinese stage I–III lung adenocarcinoma patients
Animal Models and Experimental Medicine
2022
The dual role of CD70 in B‐cell lymphomagenesis
Clinical and Translational Medicine
2021
Transcriptional landscape associated with TNBC resistance to neoadjuvant chemotherapy revealed by single-cell RNA-seq
Molecular Therapy - Oncolytics
2021
TCF/LEF regulation of the topologically associated domain ADI promotes mESCs to exit the pluripotent ground state
Cell Reports
2021
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens
Frontiers in Immunology
2021
Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
Pharmaceutics
2020
The ICOSL Expression Predicts Better Prognosis for Nasopharyngeal Carcinoma via Enhancing Oncoimmunity
BioMed Research International
2020
Osteopontin binds ICOSL promoting tumor metastasis
Communications Biology
2020
Dysregulated NF-κB–Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma
Cancer Immunology Research
2020
Blockade of PD-1, PD-L1, and TIM-3 Altered Distinct Immune- and Cancer-Related Signaling Pathways in the Transcriptome of Human Breast Cancer Explants
Genes
Additional cited-by details will be shown when available from Crossref